Avalanche Treasury Corporation filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the period ended September 30, 2026, and reporting 37,292,522 shares of Class A common stock and 5,805,639 shares of Class B common stock outstanding as of …
Advanced Biomed Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting financial results for the first fiscal quarter of its 2027 fiscal year.
EWSB Bancorp, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 12, 2026, reporting unaudited financial results for the three and nine months ended that date.
Pluri Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting financial results for the first fiscal quarter.
Vireo Growth Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 12, 2026, disclosing a significant expansion in revenue, assets, and liabilities alongside a continued net loss driven largely by income tax expenses.
GeoVax Labs, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting continued operating losses and a declining cash position.
Interlink Electronics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026.
VirTra, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, as listed on NASDAQ:VTSI.
NorthStar Earth & Space Enterprises, Inc. filed a Form 6-K on November 12, 2026, disclosing that its Audit Committee dismissed WithumSmith+Brown, PC and engaged Ernst & Young LLP as its independent registered public accounting firm, both actions effective November 11, 2026.
HeartBeam, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the fiscal quarter and nine-month period ended September 30, 2026, disclosing continued operating losses as the company advances its cardiac monitoring technology development program.